Pfizer Inc (PFE)
27.76
-0.33
(-1.17%)
USD |
NYSE |
Nov 04, 16:00
27.81
+0.05
(+0.18%)
Pre-Market: 20:00
Pfizer Adjustments for Foreign Currency Translation (Quarterly)
Adjustments for Foreign Currency Translation (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Adjustments for Foreign Currency Translation (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -- |
| March 31, 2024 | -- |
| December 31, 2023 | -- |
| September 30, 2023 | -- |
| June 30, 2023 | -- |
| March 31, 2023 | -- |
| December 31, 2022 | -- |
| September 30, 2022 | -- |
| June 30, 2022 | -- |
| March 31, 2022 | -- |
| December 31, 2021 | -- |
| September 30, 2021 | -- |
| June 30, 2021 | -- |
| March 31, 2021 | -- |
| December 31, 2020 | -- |
| September 30, 2020 | -- |
| June 30, 2020 | -- |
| March 31, 2020 | -- |
| December 31, 2019 | -- |
| September 30, 2019 | -- |
| June 30, 2019 | -- |
| March 31, 2019 | -- |
| December 31, 2018 | -- |
| September 30, 2018 | -- |
| June 30, 2018 | -- |
| Date | Value |
|---|---|
| March 31, 2018 | -- |
| December 31, 2017 | -- |
| September 30, 2017 | -- |
| June 30, 2017 | -- |
| March 31, 2017 | -- |
| December 31, 2016 | -- |
| September 30, 2016 | -- |
| June 30, 2016 | -- |
| March 31, 2016 | -- |
| December 31, 2015 | -- |
| September 30, 2015 | -- |
| June 30, 2015 | -- |
| March 31, 2015 | -- |
| December 31, 2014 | -- |
| September 30, 2014 | -- |
| June 30, 2014 | -- |
| March 31, 2014 | -- |
| December 31, 2013 | -- |
| September 30, 2013 | -- |
| June 30, 2013 | -- |
| March 31, 2013 | -- |
| December 31, 2012 | -- |
| September 30, 2012 | -- |
| June 30, 2012 | -- |
| March 31, 2012 | -- |
Adjustments for Foreign Currency Translation Definition
Adjustments for Foreign Currency Translation is a line item under shareholder's equity on the company's balance sheet. These are included to compensate for the difference between the foreign currency and the domestic currency.
Adjustments for Foreign Currency Translation (Quarterly) Range, Past 5 Years
Adjustments for Foreign Currency Translation (Quarterly) Benchmarks
| Amgen Inc | -- |
| Johnson & Johnson | -- |
| Eli Lilly and Co | -- |
| Viking Therapeutics Inc | -- |
| Moderna Inc | -- |